DelveInsight's " Aplastic Anemia Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth ...

More perceived social support from classmates was tied to less disease severity in children with sickle cell anemia in ...

Treating anemia during pregnancy might lower the risk of heart defects in newborns, a new study says. Women with anemia in ...

The FDA has approved a ready-to-dilute, multi-dose formulation of thiotepa (Tepylute) for use in breast and ovarian ...

Infection was a leading cause of death in lower-risk myelodysplastic syndromes (MDS), highlighting the need for vigilant ...

During a live event, Mark J. Fesler, MD, and participants discussed selection and timing of initiation of JAK inhibitor ...

During a live event, Mark J. Fesler, MD, and participants discuss next steps for a 68-year-old patient with intermediate-risk myelofibrosis.

Multiple myeloma can arise when plasma cells transform into malignant plasma cells which leads to the uncontrolled growth of these abnormal plasma cells.

Compare Dialysis Centers examined CDC data and other sources to explore kidney disease risk factors and why the condition has ...

A doctor has issued a warning over five symptoms said to be a sign of serious illness that is rising rapidly amongst young ...

Doctors can accurately predict a person's risk of fatty liver disease as early as 16 years before symptoms develop, a new ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...